Moderate prevalence of transmitted drug resistance and interiorization of HIV type 1 subtype C in the inland north state of Tocantins, Brazil

AIDS Research and Human Retroviruses

Volumn 27, Issue 10, 2011, Pages 1081-1087

  Carvalho, Bruna Coelho ^a   Cardoso, Ludimila Paula Vaz ^a   Damasceno, Sirlene ^b   Stefani, Mariane Martins De Araújo ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Public Health Central Laboratory of Tocantins/LACEN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ATAZANAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL RESISTANCE; ARTICLE; BRAZIL; CLINICAL ASSESSMENT TOOL; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; VIRUS MUTATION; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTI-RETROVIRAL AGENTS; BASE SEQUENCE; BRAZIL; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PREVALENCE; RNA, VIRAL; SEQUENCE ALIGNMENT; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 79959277685     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0334     Document Type: Article

References (38)

1. Brasil, Boletim Epidemiologico AIDS.DST ano VII n° 01, Programa Nacional de DST e AIDS. 2010 Ministerio da Saude: Braśilia.
2. Gallant JE: Approach to the treatment-experienced patient. Infect Dis Clin North Am 2007;21(1):85.
3. Little SJ, Holte S, Routy JP, et al.: Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347(6):385-394. (Pubitemid 34851830)
4. Ross L, Lim ML, Liao Q, et al.: Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities. HIV Clin Trials 2007;8(1):1-8. (Pubitemid 46542904)
5. Wensing AM, van d, V, Angarano G, et al.: Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management. J Infect Dis 2005;192(6):958-966. (Pubitemid 41266791)
6. Brindeiro RM, Diaz RS, Sabino EC, et al.: Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet): A survey of chronically infected individuals. AIDS 2003;17(7): 1063-1069. (Pubitemid 36549719)
7. Cardoso LP, Queiroz BB, and Stefani MM: HIV-1 pol phy-logenetic diversity and antiretroviral resistance mutations in treatment naive patients from Central West Brazil. J Clin Virol 2009;46(2):134-139.
8. Inocencio LA, Pereira AA, Sucupira MC, et al.: Brazilian Network for HIV Drug Resistance Surveillance: A survey of individuals recently diagnosed with HIV. J Int AIDS Soc 2009;12(1):20.
9. Sprinz E, Netto EM, Patelli M, et al.: Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses 2009;25(9):861-867.
10. Sanabani S, Kleine NW, Kalmar EM, et al.: Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. Infect Genet Evol 2006;6(5):368-377. (Pubitemid 43964479)
11. Sanabani S, Neto WK, de Sa Filho DJ, et al.: Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. AIDS Res Hum Retroviruses 2006;22(2): 171-176. (Pubitemid 43277153)
12. Guimaraes ML, Eyer-Silva WA, Couto-Fernandez JC, and Morgado MG: Identification of two new CRFBF in Rio de Janeiro State, Brazil. AIDS 2008;22(3):433-435.
13. Guimaraes ML, dos Santos MA, Loureiro R, Galvao-Castro B, and Morgado MG: High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. AIDS Res Hum Retroviruses 2002;18(17):1261-1269. (Pubitemid 36042986)
14. Gadelha SR, Shindo N, Cruz JN, Morgado MG, and Galvao-Castro B: Molecular epidemiology of human immunodeficiency virus-1 in the state of Ceara, Northeast, Brazil. Mem Inst Oswaldo Cruz 2003;98(4):461-463. (Pubitemid 38019603)
15. Sa Filho DJ, Sanabani S, Diaz RS, et al.: Analysis of full-length human immunodeficiency virus type 1 genome reveals a variable spectrum of subtypes B and F recombinants in Sao Paulo, Brazil. AIDS Res Hum Retroviruses 2005;21(2): 145-151. (Pubitemid 40354356)
16. Soares EA, Martinez AM, Souza TM, et al.: HIV-1 subtype C dissemination in southern Brazil. AIDS 2005;19(Suppl 4): S81-S86. (Pubitemid 41668992)
17. Sa Filho DJ, Sucupira MC, Caseiro MM, et al.: Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses 2006;22(1):1-13. (Pubitemid 43201511)
18. Santos AF, Sousa TM, Soares EA, et al.: Characterization of a new circulating recombinant form comprising HIV-1 subtypes C and B in southern Brazil. AIDS 2006;20(16):2011-2019. (Pubitemid 44611054)
19. Sanabani SS, Pastena ER, Neto WK, Martinez VP, and Sa-bino EC: Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. Virol J 2010;7:74.
20. Vicente AC, Otsuki K, Silva NB, et al.: The HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F. J Acquir Immune Defic Syndr 2000;23(4):327-331. (Pubitemid 30327035)
21. Machado LF, Vallinoto AC, Souza MI, et al.: Serological and molecular typing of HIV type 1 infection in the Tiriyo tribe, a native Indian community of the Amazon region of Brazil. AIDS Res Hum Retroviruses 2006;22(12):1267-1270. (Pubitemid 46095245)
22. Machado LF, Ishak MO, Vallinoto AC, et al.: Molecular epidemiology of HIV type 1 in northern Brazil: Identification of subtypes C and D and the introduction of CRF02-AG in the Amazon region of Brazil. AIDS Res Hum Retroviruses 2009;25(10):961-966.
23. Lehvaslaiho H, Hide W, and Oliveira T: South African National Bioinformatics Institute, University of Western Cape, South Africa. http://www.sanbi.ac.za. (May/2010, date last accessed).
24. Hall TA: BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/MT. Nucleic Acids Symp Ser 1999;41:95-98.
25. de OT, Deforche K, Cassol S, et al.: An automated geno-typing system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005;21(19):3797-3800. (Pubitemid 41535530)
26. Tamura K, Dudley J, Nei M, and Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599. (Pubitemid 47236692)
27. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of inter-subtype recombination. J Virol 1999;73(1):152-160. (Pubitemid 28565356)
28. Gifford RJ, Liu TF, Rhee SY, et al.: The calibrated population resistance tool: Standardized genotypic estimation of transmitted HIV-1 drug resistance. Bioinformatics 2009;20:1-3.
29. Andrada-Serpa MJ, Dobbin JA, Gomes P, et al.: Incidence of retroviruses in some Brazilian groups. Immunol Lett 1988; 18(1):15-18.
30. Ishak R, Harrington WJ Jr, Azevedo VN, et al.: Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11(7):813-821.
31. Shindo N, Alcantara LC, Van DS, et al.: Human retroviruses (HIV and HTLV) in Brazilian Indians: Seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res Hum Retroviruses 2002;18(1):71-77. (Pubitemid 34133030)
32. Weinstock H, Respess R, Heneine W, et al.: Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998. J Infect Dis 2000;182(1):330-333. (Pubitemid 30497825)
33. de Medeiros LB, Lacerda HR, Cavalcanti AM, and de Albuquerque MF: Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil. Mem Inst Oswaldo Cruz 2006;101(8):845-849. (Pubitemid 46131332)
34. Pedroso C, Queiroz AT, Alcantara LC, et al.: High prevalence of primary antiretroviral resistance among HIV-1-in-fected adults and children in Bahia, a northeast state of Brazil. J Acquir Immune Defic Syndr 2007;45(2):251-253. (Pubitemid 46869822)
35. Sucupira MC, Caseiro MM, Alves K, et al.: High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil. AIDS Patient Care STDS 2007;21(2):116-128. (Pubitemid 46394455)
36. Caseiro MM, Golega AA, Etzel A, and Diaz RS: Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil. Braz J Infect Dis 2008;12(3): 162-166.
37. Shafer RW: Genotypic testing for human immunodeficiency virus type 1 drug resistance. Clin Microbiol Rev 2002;15(2): 247-277. (Pubitemid 34303765)
38. Geretti AM: Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors. AIDS Rev 2006;8(4):210-220 (Pubitemid 46138919)